Want to see IN:ARTEMISMED full AI Analyst Report?
ARTEMISMED Stock Chart & Stats
₹276.20
₹1.60(0.48%)
At close: 4:00 PM EST
₹276.20
₹1.60(0.48%)
Day’s Range― - ―
52-Week Range₹202.85 - ₹378.40
Previous CloseN/A
Volume93.41K
Average Volume (3M)74.19K
Market Cap
₹49.27B
Enterprise Value₹33.06B
Total Cash (Recent Filing)₹334.05M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)40.8
Beta0.91
Next Earnings
Nov 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.14%
Share Statistics
EPS (TTM)7.64
Shares Outstanding158,306,240
10 Day Avg. Volume43,783
30 Day Avg. Volume74,194
Financial Highlights & Ratios
PEG Ratio1.41
Price to Book (P/B)3.47
Price to Sales (P/S)3.00
P/FCF Ratio100.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.28
Revenue Forecast (FY)₹13.60B
Bulls Say, Bears Say
Bulls Say
Revenue And Profit GrowthStrong multi-year revenue expansion combined with a substantial improvement in net margin indicates that Artemis has increased both scale and profitability. If sustained, this stronger earnings base can support reinvestment, improve resilience, and strengthen operating performance over the next several quarters.
Lower Financial LeverageThe marked reduction in debt relative to equity lowers balance-sheet risk and gives Artemis greater financial flexibility. A stronger equity base and more conservative leverage should improve its ability to absorb operating variability and fund business needs without relying as heavily on additional borrowing.
Positive Operating Cash FlowConsistently positive and growing operating cash flow provides evidence that the business generates cash from its operations rather than relying solely on accounting profits. This supports ongoing funding needs and provides a foundation for servicing obligations, despite uneven free-cash-flow conversion.
Bears Say
Volatile Free Cash FlowThe shift from several years of negative free cash flow to later positive periods shows that cash generation after capital spending has not been consistently dependable. Uneven conversion can constrain internally funded expansion and make financial flexibility more sensitive to investment requirements.
Recent Gross Margin PressureThe recent gross-margin decline indicates pressure within the economics of the business even though revenue and earnings continue to grow. If this lower margin level persists, it could limit operating leverage, reduce the durability of profitability gains, and make future earnings more dependent on continued volume growth.
Substantial Absolute DebtAlthough leverage has improved, the remaining absolute debt balance still creates an ongoing obligation for the company. Artemis must sustain earnings and cash generation to service it comfortably, so weaker operating performance or inconsistent cash conversion could reduce financial flexibility.
Artemis Medicare Services Ltd. News
ARTEMISMED FAQ
What was Artemis Medicare Services Ltd.’s price range in the past 12 months?
Artemis Medicare Services Ltd. lowest stock price was ₹202.85 and its highest was ₹378.40 in the past 12 months.
What is Artemis Medicare Services Ltd.’s market cap?
Artemis Medicare Services Ltd.’s market cap is ₹49.27B.
When is Artemis Medicare Services Ltd.’s upcoming earnings report date?
Artemis Medicare Services Ltd.’s upcoming earnings report date is Nov 14, 2026 which is in 31 days.
How were Artemis Medicare Services Ltd.’s earnings last quarter?
Artemis Medicare Services Ltd. released its earnings results on Aug 03, 2026. The company reported ₹2 earnings per share for the quarter.
Is Artemis Medicare Services Ltd. overvalued?
According to Wall Street analysts Artemis Medicare Services Ltd.’s price is currently Overvalued.
Does Artemis Medicare Services Ltd. pay dividends?
Artemis Medicare Services Ltd. pays a Annually dividend of ₹0.45 which represents an annual dividend yield of 0.14%. See more information on Artemis Medicare Services Ltd. dividends here
What is Artemis Medicare Services Ltd.’s EPS estimate?
Artemis Medicare Services Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Artemis Medicare Services Ltd. have?
Artemis Medicare Services Ltd. has 158,306,240 shares outstanding.
What happened to Artemis Medicare Services Ltd.’s price movement after its last earnings report?
Artemis Medicare Services Ltd. reported an EPS of ₹2 in its last earnings report. Following the earnings report the stock price went up 1.58%.
Which hedge fund is a major shareholder of Artemis Medicare Services Ltd.?
Currently, no hedge funds are holding shares in IN:ARTEMISMED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Artemis Medicare Services Ltd.
Artemis Medicare Services Limited engages in the management and operation of multi-specialty hospitals in India and internationally. The company provides medical and surgical intervention, and inpatient and outpatient services. It also offers billing and insurance, childcare, emotional and support program, full body checkup, international patient, medical interpreter and record, mind body medicine, nursing, nutrition, patient and family advisory, patient advocacy and portal, pre-admission testing, and smoking cessation program services, as well as home care services. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.
Technical Analysis
Jupiter Life Line Hospitals Ltd.
―
Rainbow Childrens Medicare Limited
―
Shalby Ltd.
―
Yatharth Hospital and Trauma Care Services Limited
―
Kovai Medical Center & Hospital Ltd.
―